[1]
A. Hassan, “Bridging the Gap between Evidence and Practice: Nationwide Retrospective Analysis of Lipid-Modifying Therapy Prescription Patterns in 5 Million Patients with Type 2 Diabetes Mellitus”, ASIDE Int Med, vol. 2, no. 2, pp. 6–11, Aug. 2025, doi: 10.71079/ASIDE.IM.08252522.